Endometriosis
Conditions
Brief summary
Characterization of the hypermetabolism of lesions on PET by analysis of SUV: Hypermetabolism present or not and quantification
Detailed description
Analyzes of lesions in Immunohistochemistry (IHC) and results of in situ hybridization: Characterization of the markings (intensity, type of receptor expressed, etc.) for each lesion depending on the anatomical location., Analyzes of lesions in Immunohistochemistry and results of in situ hybridization: Characterization of the markings (intensity, type of receptor expressed, etc.) for each patient according to pain (VAS), Sensitivity of [18F]-FES PET/CT compared to that of MRI in the diagnosis of superficial and deep endometriosis lesions and according to their location, Degree of association between [18F] SUV intensity and ER expression (IHC) and pain intensity (VAS)
Interventions
DRUGsolution injectable
Sponsors
Centre Hospitalier Universitaire De Toulouse
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Characterization of the hypermetabolism of lesions on PET by analysis of SUV: Hypermetabolism present or not and quantification | — |
Secondary
| Measure | Time frame |
|---|---|
| Analyzes of lesions in Immunohistochemistry (IHC) and results of in situ hybridization: Characterization of the markings (intensity, type of receptor expressed, etc.) for each lesion depending on the anatomical location., Analyzes of lesions in Immunohistochemistry and results of in situ hybridization: Characterization of the markings (intensity, type of receptor expressed, etc.) for each patient according to pain (VAS), Sensitivity of [18F]-FES PET/CT compared to that of MRI in the diagnosis of superficial and deep endometriosis lesions and according to their location, Degree of association between [18F] SUV intensity and ER expression (IHC) and pain intensity (VAS) | — |
Countries
France
Outcome results
None listed